Published February 5, 2008 | Version v1
Patent Open

Induction of immunity using inhibitors of granzymes

  • 1. University of Chicago

Contributors

Patent applicant:

Description

The present invention provides methods for enhancing host immunity to a virus and/or a cancer and methods for enhancing the cytotoxic T-cell (CTL) mediated immune responses by providing granzyme B inhibitors to a subject. One objective of the invention is to induce long-term protective immunity to a subject in need thereof This is accomplished by providing granzyme inhibitors to the subject which increase the number of memory-CTLs and thereby prevent or alleviate viral infections and/or treat. Providing granzyme inhibitors is also effective in the prevention of cancers. Some examples of granzyme inhibitors contemplated within the present invention include the endogenous serpins such as SPI6 and PI9, other suicide substrates of granzyme B, granzyme B antibodies, etc. Also provided are methods for expression of nucleic acids encoding granzyme inhibitors in cytotoxic T-lymphocytes (CTLs).

Files

US7326692.pdf

Files (2.5 MB)

Name Size Download all
md5:afb903659ae16c3c8bcbe542af0c4dd0
2.5 MB Preview Download

Additional details

Identifiers

Patent application number
US 99336301 A
Patent number
US 7326692 B2
Other
oai:uchicago.tind.io:8481

Dates

Patent filed
2001-11-14

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Immunology